John G. Stratton
Director · ABBOTT LABORATORIES
IndividualBuying only
- 2024
- Oct 2, 2026
- 17
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John G. Stratton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Phebe N. Novakovic - $31.38M in GD purchases and sales in the last 12 months
- Mark Lagrand Burns - $28.64M in GD purchases and sales in the last 12 months
- Marguerite Amy Gilliland - $17.67M in GD purchases and sales in the last 12 months
- David Paddock - $6.82M in GD purchases and sales in the last 12 months
- Robert K. Steel - $2.57M in GD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John G. Stratton?
John G. Stratton is a corporate insider, tracked as Director of ABBOTT LABORATORIES (ABT). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John G. Stratton submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has John G. Stratton been buying or selling stock?
Recorded transactions: 1 open-market purchase ($174K) and 0 open-market sales across all tracked filings.
